| Cat.No. | Name | Information |
|---|---|---|
| M3470 | Oxybutynin | Oxybutynin is an anticholinergic medication used to relieve urinary and bladder difficulties. |
| M3190 | PNU-282987 | PNU-282987 is a highly selective α7 nAChR agonist with Ki of 27 nM. |
| M54823 | THRX-160209 | THRX-160209 is a potent antagonist at the M(2) muscarinic acetylcholine (ACh) receptor subtype that was designed using a multivalent strategy, simultaneously targeting the orthosteric site and a nearby site known to bind allosteric ligands. |
| M54437 | Catestatin | Catestatin is a 21-amino acid residue, cationic and hydrophobic peptide. |
| M54385 | α-Conotoxin MII | α-Conotoxin MII (α-CTxMII), a 16-amino acid peptide from the venom of the marine snail Conus magus, potently blocks nicotinic acetylcholine receptors (nAChRs) composed of α3β2 subunits, with an IC50 of 0.5 nM. |
| M54173 | COG 133 TFA | COG 133 TFA is a fragment of Apolipoprotein E (APOE) peptide. |
| M53102 | G-Protein antagonist peptide | G-Protein antagonist peptide is the substance P-related peptide that inhibits binding of G proteins to their receptors. |
| M53101 | α-Conotoxin M I | α-Conotoxin M I is a potent and selective inhibitor of mAChR and α1β1γδ nAChR, but has no effect on nicotine-stimulated dopamine release. |
| M52775 | α-Conotoxin PnIA | α-Conotoxin PnIA, a potent and selective antagonist of the mammalian α7 nAChR, has the potential for the research of neurological conditions such as neuropathic pain and Alzheimer’s disease. |
| M52774 | κ-Bungarotoxin | κ-Bungarotoxin (κ-Bgt) is a potent, selective, and slowly reversible antagonist of α3β2 neuronal nicotinic acetylcholine receptors with an IC50 of 2.30 nM. |
| M52773 | Rabies Virus Matrix Protein Fragment(RV-MAT) | Rabies Virus Matrix Protein Fragment (RV-MAT) is a polypeptide. |
| M52772 | αO-Conotoxin GeXIVA | αO-Conotoxin GeXIVA is a potent α9α10 nAChR antagonist with an IC50 of 12 nM against rat α9α10. |
| M52771 | αA-Conotoxin OIVA | αA-Conotoxin OIVA (αA-OIVA) is a selective nAChR antagonist with an IC50 of 56 nM against mammalian fetal muscle nAChR. |
| M52770 | αA-Conotoxin PIVA | αA-Conotoxin PIVA is a selective mouse musclenAChR inhibitor with IC50 for adult and fetal mouse musclenAChR sub> values are 2.3 nM and 22 nM respectively. |
| M52769 | α-Conotoxin AuIA | α-Conotoxin AuIA is a potent and selective α3β4 n-nAChR inhibitor. |
| M52768 | α-Conotoxin BuIA | α-Conotoxin BuIA is a paralytic peptide neurotoxin and a competitive nAChR antagonist, with IC50s of 0.258 nM (α6/α3β2), 1.54 nM (α6/α3β4), 5.72 nM (α3β2), respectively. |
| M52767 | α-Conotoxin Im-I | α-Conotoxin Im-I is a selective α7/α9 nAChR antagonist, blocking α7 nicotinic receptors with the highest apparent affinity, while having an 8-fold lower affinity for homomeric α9 nicotinic receptors. |
| M52766 | α-Conotoxin MrIC | α-Conotoxin MrIC is an α7nAChR biased agonist. |
| M52765 | α-Conotoxin PeIA | α-Conotoxin PeIA is an analgesic α-conotoxin.α-Conotoxin PeIA inhibits the α6β4, α9α10 and α3β2 nAChR.α-Conotoxin PeIA is also a potent inhibitor of N-type calcium channel via GABAB receptor activation. |
| M52764 | α-Conotoxin RgIA | α-Conotoxin RgIA (α-RgIA) is a specific α9α10 nAChR antagonist. |
| M52763 | α-Conotoxin S IA | α-Conotoxin SIA is a selective nicotinic acetylcholine receptor (nAChR) antagonist with high affinity for the muscle nAChR. |
| M52762 | α-Conotoxin TxID | α-Conotoxin TxID is a potent α3β4 nAChR antagonist with an IC50 value of 12.5 nM. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
